Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Aug 14, 2019 12:41pm

95 Views

Post# 30027688

RE:RE:Where Is Official Delay Til 22nd?

Dreimer200 wrote: For what it is worth -- I spoke to the investor relations rep at the company yesterday, She said there was no more room in the placement. The change in date is a technicality.

Interesting. Ok. So this means there is plenty of cash to get this thing moving. The financial aspect at least for awhile has been taken care of. What then is causing a drag on the share price? Is it going to take seeing phase 2 results before share price heads up? What else could it be?

Bullboard Posts

Sirios Resource discovers visible gold in Quebec